|
Vaccine-Positive, Vaccine-Negative, and Don't Know/Undecided Responses Related to Demographic Characteristics |
||||
| # Positive responses |
# Negative responses |
# Don't know/undecided responses |
||
|
|
||||
| N |
Mean (S.D.) |
Mean (S.D.) |
Mean (S.D.) |
|
|
|
||||
| Gender |
||||
| Male |
525 |
12.19 (3.84) |
3.88 (2.80) |
3.85 (3.01) |
| Female |
532 |
11.77 (3.75) |
3.80 (2.60) |
4.37 (2.93)** |
| Marital Status |
||||
| Single (never married) |
294 |
11.85 (3.85) |
3.91 (2.86) |
4.18 (2.96) |
| Married / common-law |
620 |
12.06 (3.75) |
3.89 (2.70) |
3.98 (2.88) |
| Widowed |
52 |
11.23 (4.15) |
3.61 (2.33) |
5.09 (3.83) |
| Separated |
25 |
12.96 (3.41) |
2.84 (1.79) |
4.16 (2.79) |
| Divorced |
49 |
12.57 (3.26) |
3.43 (2.27) |
3.96 (3.02) |
| Children |
||||
| Yes |
721 |
12.10 (3.74) |
3.84 (2.66) |
4.00 (2.94) |
| No |
327 |
11.77 (3.85) |
3.88 (2.80) |
4.29 (2.98) |
| Age Quartile (years) |
||||
| 18–32 |
256 |
12.01 (3.55) |
3.64 (2.57) |
4.33 (2.90) |
| 33–42 |
252 |
11.80 (3.90) |
4.00 (2.83) |
4.17 (2.92) |
| 43–55 |
263 |
12.18 (3.71) |
4.01 (2.74) |
3.74 (2.93) |
| 56–88 |
256 |
12.20 (3.90) |
3.62 (2.62) |
4.08 (3.08) |
| Education |
||||
| Less than high school |
157 |
11.41 (3.41) |
4.19 (2.56) |
4.34 (3.23) |
| High school completed |
307 |
11.64 (3.77) |
3.81 (2.45) |
4.47 (3.04) |
| Some college/ university |
132 |
12.24 (3.39) |
3.79 (2.71) |
3.87 (2.50) |
| College diploma |
186 |
11.75 (4.08) |
4.23 (3.05) |
4.01 (2.89) |
| University undergraduate degree |
200 |
12.75 (4.00) |
3.34 (2.78) |
3.89 (3.05) |
| University Masters degree |
51 |
12.96 (3.41) |
3.63 (2.73) |
3.33 (2.41) |
| University Doctorate degree |
9 |
14.55 (4.36) ** |
2.44 (2.24) * |
3.00 (3.84) * |
| Employment |
||||
| Full-time |
534 |
12.06 (3.85) |
3.85 (2.72) |
4.04 (3.01) |
| Part-time |
122 |
11.98 (3.50) |
3.74 (2.75) |
4.20 (2.67) |
| Not presently employed |
393 |
11.92 (3.79) |
3.85 (2.67) |
4.16 (3.04) |
| Residence |
||||
| Urban |
698 |
12.03 (3.85) |
3.78 (2.81) |
4.13 (2.98) |
| Rural |
338 |
11.94 (3.68) |
3.95 (2.49) |
4.05 (2.95) |
|
* p < 0.05 between groups in ANOVA (with linear trend where applicable) ** p < 0.01 between groups in ANOVA (with linear trend where applicable) | ||||
Ritvo et al. Journal of Immune Based Therapies and Vaccines 2003 1:3 doi:10.1186/1476-8518-1-3 |
||||